Table 4.
Age | Mean | SD | n |
---|---|---|---|
⩽35 years | 2.2 | 1.3 | 75 |
36–60 years | 2.2 | 1.3 | 288 |
>60 years | 2.0 | 1.2 | 191 |
Number of risk factors | |||
0 | 1.7 | 1.3 | 35 |
1 | 2.1 | 1.4 | 134 |
2 | 2.1 | 1.2 | 240 |
3 | 2.1 | 1.2 | 110 |
4 | 2.3 | 1.3 | 35 |
Initial dose a | |||
1 | 2.3 | 1.6 | 103 |
2 | 2.2 | 1.5 | 92 |
3 | 2.2 | 1.4 | 128 |
4 | 2.1 | 1.4 | 120 |
5 | 1.8 | 1.1 | 111 |
Sex | |||
Men | 1.8 | 1.0 | 109 |
Women | 2.2 | 1.3 | 445 |
Length of tapering trajectory in days | |||
28 | 2.3 | 1.4 | 270 |
56 | 2.1 | 1.2 | 150 |
84 | 2.0 | 0.9 | 81 |
112 | 2.0 | 1.3 | 33 |
140 | 2.1 | 0.8 | 20 |
Use of any stabilisation strip | |||
No | 2.1 | 1.3 | 535 |
Yes | 2.5 | 1.0 | 19 |
Medication type | |||
Other | 2.0 | 1.2 | 198 |
Paroxetine | 2.3 | 1.1 | 134 |
Venlafaxine | 2.1 | 1.4 | 222 |
Expressed as units of daily defined dose and divided by its quintiles, to create quintile groups.